Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-22
1992-03-31
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514326, 514399, 546210, 548336, 548337, 548341, A61K 31415, A61K 31445, C07D40312, C07D40112
Patent
active
051009099
ABSTRACT:
Acetylenic imidazole compounds having cholinergic agonist or antagonist activity useful in the treatment of mental disorders, extrapyramidal motor disorders, disorders of the parasympathetic nervous system and glaucoma or as analgesics for the treatment of pain. Typical central nervous system disorders for which the subject compounds can be used include cognitive disorders of all ages, including senile dementia, Alzheimer's disease and other related disorders. The compounds are particularly developed to improve mental performance when a mental deficiency is diagnosed.
REFERENCES:
patent: 3925411 (1975-12-01), Dahlbom
patent: 3959311 (1976-05-01), Dahlbom
patent: 4463001 (1984-07-01), Melloni et al.
patent: 4721783 (1988-01-01), Davis
Press et al., J. Med. Chem., 29, 816-819 (1986).
Ringdahl, B., J. Med. Chem. 31, No. 3, 683-688 (1988).
Nilsson, et al, J. Med. Chem., 31 No. 3, 577-582 (1988).
Heier Richard F.
Moon Malcolm W.
Corneglio Donald
Lee Mary C.
Miltenberger Lenora
The Upjohn Company
LandOfFree
Acetylenic imidazoles having central nervous system activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylenic imidazoles having central nervous system activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylenic imidazoles having central nervous system activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2259571